Joshua J. Freemire, Member of the Firm in the Health Care & Life Sciences practice, in the firm’s Baltimore office, was quoted in PE HUB in “Hg Said to Reap Premium Multiples from $2.3bn Intelerad Sale; HIG Capital Invests in Medicaid Services Provider” by John R. Fischer.
The following is an excerpt:
PE sees opportunities to provide capital to help these service providers facilitate improvements as well as grow and expand in the fragmented Medicaid space.
But following the passage of the One Big Beautiful Bill this summer, federal spending on Medicaid is expected to drop by over $900 billion over the next ten years and lead to millions losing their Medicaid coverage and limited access for others. The changes and cuts will be implemented over several years, with the first provisions to take effect in 2026. …
Joshua Freemire, a partner at Epstein Becker & Green, told me that companies focused on reducing costs and increasing access at lower costs are likely to attract more attention from PE than others. "I think of remote technologies, Al-driven solutions that purport to lower costs, alternative site solutions that lower costs, lower cost staffing, etc." …
